JESSE MARTINEZ: Open Payments
NPI 1023234341 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,955 in 64 payments from 16 companies in 2025. Trend: 2023 $2,179 · 2024 $2,862 · 2025 $2,955
Food & beverage: $2,955
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 25 | $861 |
| Exact Sciences Corporation | 7 | $303 |
| AstraZeneca Pharmaceuticals LP | 4 | $279 |
| Corcept Therapeutics | 2 | $278 |
| Novo Nordisk Inc | 4 | $188 |
| Lilly USA, LLC | 5 | $166 |
| Baxter Healthcare | 1 | $150 |
| Boston Scientific Corporation | 1 | $146 |
| PFIZER INC. | 3 | $137 |
| ABBVIE INC. | 1 | $124 |
Products named: Kerendia, Korlym, Cologuard Collection Kit, FLOSEAL, AMS 700, Ozempic, AIRSUPRA, MOUNJARO.
Industry payments across TX — which companies pay providers there.
